Foresite Capital Opportunity Management V, LLC Enanta Pharmaceuticals Inc Transaction History
Foresite Capital Opportunity Management V, LLC
- $33.3 Million
- Q3 2022
A detailed history of Foresite Capital Opportunity Management V, LLC transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Foresite Capital Opportunity Management V, LLC holds 22,750 shares of ENTA stock, worth $247,292. This represents 3.54% of its overall portfolio holdings.
Number of Shares
22,750
Previous 22,750
-0.0%
Holding current value
$247,292
Previous $1.08 Million
9.77%
% of portfolio
3.54%
Previous 2.71%
Shares
1 transactions
Others Institutions Holding ENTA
# of Institutions
102Shares Held
21.1MCall Options Held
10.4KPut Options Held
2.3K-
Farallon Capital Management LLC San Francisco, CA2.1MShares$22.8 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.93MShares$21 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.85MShares$20.1 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.46MShares$15.8 Million0.0% of portfolio
-
Krensavage Asset Management, LLC New York, NY1.25MShares$13.6 Million7.45% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $225M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...